EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome

Alexandra E Butler iD, Walaa Lubbad iD, Shahzad Akbar iD, Eric S Kilpatrick, Thozhukat Sathyapalan iD, Stephen L Atkin iD

International Journal of Molecular Sciences · 30.04.2024 · 25 (9) · 4899

DOI: 10.3390/ijms25094899 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.04.2024. Verfasst von Alexandra E Butler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, Royal College of Surgeons in Ireland Bahrain, Busaiteen, Adliya P.O. Box 15503, Bahrain. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Glomerular Filtration Rate, Biomarkers, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glomerular hyperfiltration (GH) has been reported to be higher in women with polycystic ovary syndrome (PCOS) and is an independent risk factor for renal function deterioration, metabolic, and cardiovascular disease. The aim of this study was to determine GH in type A PCOS subjects and to identify whether inflammatory markers, markers of CKD, renal tubule injury markers, and complement system proteins were associated. In addition, a secondary cohort study was performed to determine if the eGFR had altered over time. In this comparative cross-sectional analysis, demographic, metabolic, and proteomic data from Caucasian women aged 18–40 years from a PCOS Biobank (137 with PCOS, 97 controls) was analyzed. Slow Off-rate Modified Aptamer (SOMA)-scan plasma protein measurement was undertaken for inflammatory proteins, serum markers of chronic kidney disease (CKD), tubular renal injury markers, and complement system proteins. A total of 44.5% of the PCOS cohort had GH (eGFR ≥ 126 mL/min/1.73 m2 (n = 55)), and 12% (n = 17) eGFR ≥ 142 mL/min/1.73 m2 (super-GH(SGH)). PCOS-GH women were younger and had lower creatinine and urea versus PCOS-nonGH. C-reactive protein (CRP), white cell count (WCC), and systolic blood pressure (SBP) were higher in PCOS versus controls, but CRP correlated only with PCOS-SGH alone. Complement protein changes were seen between controls and PCOS-nonGH, and decay-accelerator factor (DAF) was decreased between PCOS-nonGH and PCOS-GSGH (p < 0.05). CRP correlated with eGFR in the PCOS-SGH group, but not with other inflammatory or complement parameters. Cystatin-c (a marker of CKD) was reduced between PCOS-nonGH and PCOS-GSGH (p < 0.05). No differences in tubular renal injury markers were found. A secondary cohort notes review of the biobank subjects 8.2–9.6 years later showed a reduction in eGFR: controls −6.4 ± 12.6 mL/min/1.73 m2 (−5.3 ± 11.5%; decrease 0.65%/year); PCOS-nonGH −11.3 ± 13.7 mL/min/1.73 m2 (−9.7 ± 12.2%; p < 0.05, decrease 1%/year); PCOS-GH (eGFR 126–140 mL/min/17.3 m2) −27.1 ± 12.8 mL/min/1.73 m2 (−19.1 ± 8.7%; p < 0.0001, decrease 2%/year); PCOS-SGH (eGFR ≥ 142 mL/min/17.3 m2) −33.7 ± 8.9 mL/min/17.3 m2 (−22.8 ± 6.0%; p < 0.0001, decrease 3.5%/year); PCOS-nonGH eGFR versus PCOS-GH and PCOS-SGH, p < 0.001; no difference PCOS-GH versus PCOS-SGH. GH was associated with PCOS and did not appear mediated through tubular renal injury; however, cystatin-c and DAF were decreased, and CRP correlated positively with PCOS-SGH, suggesting inflammation may be involved at higher GH. There were progressive eGFR decrements for PCOS-nonGH, PCOS-GH, and PCOS-SGH in the follow-up period which, in the presence of additional factors affecting renal function, may be clinically important in the development of CKD in PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeGlomerular Filtration RateBiomarkersRenal Insufficiency, ChronicHumansFemaleAdultCross-Sectional StudiesYoung AdultAdolescentC-Reactive ProteinKidney Glomerulus

Stichwörter der Autor:innen

complement proteinglomerular filtration ratehyperfiltrationinflammationpolycystic ovarian syndrome

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Research Department, Royal College of Surgeons in Ireland Bahrain, Busaiteen, Adliya P.O. Box 15503, Bahrain.
  • Allam Diabetes Centre, Hull University Teaching Hospitals NHS Trust, Hull HU3 2JZ, UK.
  • Sidra Medicine, Doha P.O. Box 26999, Qatar.
  • Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU6 7RU, UK.

ORCID-Profile: Alexandra E Butler, Walaa Lubbad, Shahzad Akbar, Thozhukat Sathyapalan, Stephen L Atkin

Zitieren

APA

Butler, A. E., Lubbad, W., Akbar, S., Kilpatrick, E. S., Sathyapalan, T., & Atkin, S. L. (2024). A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome. International Journal of Molecular Sciences, 25(9), 4899. https://doi.org/10.3390/ijms25094899

Vancouver

Butler AE, Lubbad W, Akbar S, Kilpatrick ES, Sathyapalan T, Atkin SL. A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome. International Journal of Molecular Sciences. 2024;25(9):4899. doi:10.3390/ijms25094899

BibTeX
@article{Butler2024,
  author = {Butler, Alexandra E and Lubbad, Walaa and Akbar, Shahzad and Kilpatrick, Eric S and Sathyapalan, Thozhukat and Atkin, Stephen L},
  title = {A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {9},
  pages = {4899},
  doi = {10.3390/ijms25094899}
}
Kostenlos starten →